Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
21 hedge funds and large institutions have $69.6M invested in Sinovac Biotech, Ltd in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
13% more capital invested
Capital invested by funds: $61.7M → $69.6M (+$7.91M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less funds holding
Funds holding: 24 → 21 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
-$1.18K |
| 2 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$419 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $38.2M | – | – | – |
|
|
O
2
OrbiMed
New York
| $25.5M | – | – | – |
|
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
4
Renaissance Technologies
New York
| $1.54M | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $1.04M | – | – | – |
|
|
YMRC
6
Yorktown Management & Research Company
Forest,
Virginia
| $485K | – | – | – |
|
7
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
| $259K | – | – | – |
|
8
Geode Capital Management
Boston,
Massachusetts
| $179K | – | – | – |
|
|
FIM
9
Freedom Investment Management
Hartford,
Connecticut
| $133K | -$419 | -65 | -0.3% |
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $59K | +$3.49K | +538 | +6% |
|
12
Northern Trust
Chicago,
Illinois
| $55K | – | – | – |
|
13
Morgan Stanley
New York
| $9K | – | – | – |
|
14
Group One Trading
Chicago,
Illinois
| $3K | – | – | – |
|
15
JP Morgan Chase
New York
| $3K | – | – | – |
|
|
FGAM
16
Financial Gravity Asset Management
Lakeway,
Texas
| – | -$1.18K | -184 | Closed |
|
SVA Hedge Fund Activity: Q2 2020 in Review
21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q2 2020, worth a combined $69.6M — up 13% from $61.7M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SVA and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $3.49K. The largest seller was Financial Gravity Asset Management, exiting entirely with an estimated $1.18K sold.
- 21 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q2 2020, down from 24 in Q1 2020.
- Funds reported $69.6M of Sinovac Biotech, Ltd stock for Q2 2020, up 13% quarter-over-quarter.
- 0 funds opened new Sinovac Biotech, Ltd positions in Q2 2020 and 3 closed out, a net change of -3 holders.
- The largest Sinovac Biotech, Ltd buyer in Q2 2020 was UBS Group, an estimated $3.49K added.
- The largest Sinovac Biotech, Ltd seller in Q2 2020 was Financial Gravity Asset Management, an estimated $1.18K sold.
Based on aggregated 13F filings for Q2 2020.